Cargando…
Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
Background: To better understand the epidemiology of primary Epstein-Barr virus (EBV) infection and to identify EBV-naïve candidates eligible to receive a prophylactic EBV vaccine, we screened freshmen from the University of Minnesota Class of 2025 for circulating EBV antibody, which is indicative o...
Autores principales: | Balfour, Henry H., Meirhaeghe, Madeline R., Stancari, Arianna L., Geris, Jennifer M., Condon, Lawrence M., Cederberg, Laurel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505200/ https://www.ncbi.nlm.nih.gov/pubmed/36146477 http://dx.doi.org/10.3390/vaccines10091399 |
Ejemplares similares
-
Screening for Epstein–Barr virus (EBV) infection status in university freshmen: acceptability of a gingival swab method
por: Grimm-Geris, J. M., et al.
Publicado: (2019) -
Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine
por: Liu, Hui, et al.
Publicado: (2020) -
Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome
por: Torti, Lorenza, et al.
Publicado: (2012) -
Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012) -
Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV
por: Venturini, Cristina, et al.
Publicado: (2021)